|
Peptides
FLIP Peptide
Background
FLIP (C-Terminus) Peptide
Location
18 amino acids near the carboxy terminus of human FLIP.
Application
FLIP peptide is used for blocking the activity of Anti-FLIP? (Cat. No. 1161). Incubating the peptide with equal volume of antibody for 30 min at 37˚C usually completely blocks the antibody activity in Western blotting.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
FLIP peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
H
Short Description
(CT) FLIP peptide
This product belongs to the following categories:
Related Products
References- Schievella AR, Chen JH, Graham JR, Lin LL. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem 1997;272:12069-12075
- Chow VT, Lee SS. DENN, a novel human gene differentially expressed in normal and neoplastic cells. DNA Seq 1996;6:263-273
- Zhang Y, Zhou L, Miller CA. A splicing variant of a death domain protein that is regulated by a mitogen-activated kinase is a substrate for c-Jun N-terminal kinase in the human central nervous system. Proc Natl Acad Sci U S A 1998;95:2586-2591
- Brown TL and Howe PH. MADD is highly homologous to a Rab3 guanine-nucleotide exchange protein (Rab3-GEP). Curr Biol 1998;8:R191
Datasheet 0801-W
|
|
